{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:19:26Z","timestamp":1773364766489,"version":"3.50.1"},"reference-count":39,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":647,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1002\/jcph.222","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T04:42:37Z","timestamp":1383799357000},"page":"133-140","source":"Crossref","is-referenced-by-count":9,"title":["The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteers"],"prefix":"10.1002","volume":"54","author":[{"given":"Herta M.","family":"Crauwels","sequence":"first","affiliation":[{"name":"From Janssen Infectious Diseases BVBA; Beerse Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf P.G.","family":"van Heeswijk","sequence":"additional","affiliation":[{"name":"From Janssen Infectious Diseases BVBA; Beerse Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Vandevoorde","sequence":"additional","affiliation":[{"name":"From Janssen Infectious Diseases BVBA; Beerse Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemie","family":"Buelens","sequence":"additional","affiliation":[{"name":"From Janssen Infectious Diseases BVBA; Beerse Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marita","family":"Stevens","sequence":"additional","affiliation":[{"name":"From Janssen Infectious Diseases BVBA; Beerse Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.W.","family":"Hoetelmans","sequence":"additional","affiliation":[{"name":"From Janssen Infectious Diseases BVBA; Beerse Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,11,23]]},"reference":[{"key":"10.1002\/jcph.222-BIB0001|jcph222-cit-0001","unstructured":"http:\/\/www.edurant.com\/sites\/default\/files\/EDURANT-PI.pdf"},{"key":"10.1002\/jcph.222-BIB0002|jcph222-cit-0002","unstructured":"http:\/\/www.medicines.org.uk\/EMC\/medicine\/25490\/SPC\/Edurant+25+mg+tablets\/#DOCREVISION"},{"key":"10.1002\/jcph.222-BIB0003|jcph222-cit-0003","unstructured":"http:\/\/www.gilead.com\/pdf\/complera_pi.pdf"},{"key":"10.1002\/jcph.222-BIB0004|jcph222-cit-0004","unstructured":"http:\/\/www.medicines.org.uk\/emc\/medicine\/25518\/SPC\/"},{"key":"10.1002\/jcph.222-BIB0005|jcph222-cit-0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/QAI.0b013e31824d006e","article-title":"Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-na\u00efve, HIV-1-infected patients: pooled results from the phase 3 double-blind, randomized ECHO and THRIVE trials","volume":"60","author":"Cohen","year":"2012","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.222-BIB0006|jcph222-cit-0006","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(11)60936-7","article-title":"For the ECHO study group. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-na\u00efve adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial","volume":"378","author":"Molina","year":"2011","journal-title":"Lancet."},{"key":"10.1002\/jcph.222-BIB0007|jcph222-cit-0007","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(11)60983-5","article-title":"For the THRIVE Study Group. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-na\u00efve adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial","volume":"378","author":"Cohen","year":"2011","journal-title":"Lancet."},{"key":"10.1002\/jcph.222-BIB0008|jcph222-cit-0008","unstructured":"van Heeswijk R Hoetelmans R Kestens D"},{"key":"10.1002\/jcph.222-BIB0009|jcph222-cit-0009","unstructured":"Crauwels HM van Heeswijk RPG Stevens T"},{"key":"10.1002\/jcph.222-BIB0010|jcph222-cit-0010","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","article-title":"Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic","volume":"17","author":"Tyndall","year":"2003","journal-title":"AIDS."},{"key":"10.1002\/jcph.222-BIB0011|jcph222-cit-0011","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QAD.0b013e32834f19b6","article-title":"HIV infection and risk of overdose: a systematic review and meta-analysis","volume":"26","author":"Green","year":"2012","journal-title":"AIDS."},{"key":"10.1002\/jcph.222-BIB0012|jcph222-cit-0012","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice","year":"2010","journal-title":"Lancet."},{"key":"10.1002\/jcph.222-BIB0013|jcph222-cit-0013","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J Addict Dis."},{"key":"10.1002\/jcph.222-BIB0014|jcph222-cit-0014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0376-8716(00)00121-6","article-title":"Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment","volume":"61","author":"Eap","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1002\/jcph.222-BIB0015|jcph222-cit-0015","unstructured":"http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/UCM142842.pdf"},{"key":"10.1002\/jcph.222-BIB0016|jcph222-cit-0016","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.106.117580","article-title":"Enantiomeric metabolic interactions and stereoselective human methadone metabolism","volume":"321","author":"Totah","year":"2007","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1002\/jcph.222-BIB0017|jcph222-cit-0017","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JCP.0b013e3180592ad2","article-title":"Increased (R)-methadone plasma concentrations of quetiapine in cytochrome P450s and ABCB1 genotyped patients","volume":"27","author":"Uehlinger","year":"2007","journal-title":"J Clin Psychopharmacol."},{"key":"10.1002\/jcph.222-BIB0018|jcph222-cit-0018","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1526-4637.2006.00289.x","article-title":"Actual and potential-drug interactions associated with methadone","volume":"9","author":"Weschules","year":"2008","journal-title":"Pain Med."},{"key":"10.1002\/jcph.222-BIB0019|jcph222-cit-0019","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2008.104","article-title":"Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. evidence against CYP3A4 mediation of methadone clearance","volume":"84","author":"Kharasch","year":"2008","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.222-BIB0020|jcph222-cit-0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2125.2001.00342.x","article-title":"The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz","volume":"51","author":"Clarke","year":"2001","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.222-BIB0021|jcph222-cit-0021","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00228-007-0299-z","article-title":"Pharmacokinetics of methadone in human-immunodeficiency-virus-infected patients receiving nevirapine once daily","volume":"63","author":"Arroyo","year":"2007","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1002\/jcph.222-BIB0022|jcph222-cit-0022","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/376907","article-title":"The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients","volume":"37","author":"McCance-Katz","year":"2003","journal-title":"Clin Infect Dis."},{"key":"10.1002\/jcph.222-BIB0023|jcph222-cit-0023","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0091270007310387","article-title":"Pharmacokinetic and pharmacodynamic study of the concomitant administration of methadone and TMC125 in HIV-negative volunteers","volume":"48","author":"Sch\u00f6ller-Gy\u00fcre","year":"2008","journal-title":"J Clin Pharmacol."},{"key":"10.1002\/jcph.222-BIB0024|jcph222-cit-0024","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0091270010365558","article-title":"Pharmacokinetic interactions between darunavir\/ritonavir and opioid maintenance therapy using methadone or buprenorphine\/naloxone","volume":"51","author":"Sekar","year":"2011","journal-title":"J Clin Pharmacol."},{"key":"10.1002\/jcph.222-BIB0025|jcph222-cit-0025","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jcph.107","article-title":"Impact of food and different meal types on the pharmacokinetics of rilpivirine","volume":"53","author":"Crauwels","year":"2013","journal-title":"J Clin Pharmacol."},{"key":"10.1002\/jcph.222-BIB0026|jcph222-cit-0026","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","article-title":"The development of a short opiate withdrawal scale (SOWS). Brief report","volume":"15","author":"Gossop","year":"1990","journal-title":"Addict Behav."},{"key":"10.1002\/jcph.222-BIB0027|jcph222-cit-0027","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0306-4603(01)00201-5","article-title":"Initial validation of two opiate craving questionnaires: the obsessive compulsive drug use scale and the desires for drug questionnaire","volume":"27","author":"Franken","year":"2002","journal-title":"Addict Behav."},{"key":"10.1002\/jcph.222-BIB0028|jcph222-cit-0028","doi-asserted-by":"crossref","DOI":"10.5414\/CP201943","article-title":"Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteers","author":"Crauwels","year":"2013","journal-title":"Int J Clin Pharmacol Ther."},{"key":"10.1002\/jcph.222-BIB0029|jcph222-cit-0029","unstructured":"Crauwels H Stevens M Buelens A"},{"key":"10.1002\/jcph.222-BIB0030|jcph222-cit-0030","unstructured":"Crauwels H Stevens M De la Rosa G Boven K."},{"key":"10.1002\/jcph.222-BIB0031|jcph222-cit-0031","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2125.2000.00272.x","article-title":"Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients","volume":"50","author":"Foster","year":"2000","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.222-BIB0032|jcph222-cit-0032","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2125.2005.02464.x","article-title":"Within- and between-subject variability in methadone pharmacokinetics and pharmacdynamics in methadone maintenance subjects","volume":"60","author":"Hanna","year":"2005","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.222-BIB0033|jcph222-cit-0033","unstructured":"http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm292362.pdf"},{"key":"10.1002\/jcph.222-BIB0034|jcph222-cit-0034","unstructured":"Crauwels HM van Heeswijk RPG Stevens M"},{"key":"10.1002\/jcph.222-BIB0035|jcph222-cit-0035","unstructured":"Prezista US Prescribing Information. February 2013 http:\/\/www.prezista.com\/sites\/default\/files\/pdf\/us_package_insert.pdf#zoom=100"},{"key":"10.1002\/jcph.222-BIB0036|jcph222-cit-0036","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11904-010-0048-2","article-title":"Methadone, buprenorphine, and street drug interactions with antiretroviral medications","volume":"7","author":"Gruber","year":"2010","journal-title":"Curr HIV\/AIDs Rep."},{"key":"10.1002\/jcph.222-BIB0037|jcph222-cit-0037","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone - metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res."},{"key":"10.1002\/jcph.222-BIB0038|jcph222-cit-0038","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opiods, methadone and buprenorphine, and other frequently prescribed medications: a review","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am J Addict."},{"key":"10.1002\/jcph.222-BIB0039|jcph222-cit-0039","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1177\/0091270009360981","article-title":"Effect of raltegravir on the pharmacokinetics of methadone","volume":"50","author":"Anderson","year":"2010","journal-title":"J Clin Pharmacol."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.222","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.222\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:02:59Z","timestamp":1657803779000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.222"}},"subtitle":["Journal of Clinical Pharmacology"],"short-title":[],"issued":{"date-parts":[[2013,11,23]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.222","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,23]]}}}